How do circulatory system and immune system work together to respond to an injury

The immune system protects the body from possibly harmful substances by recognizing and responding to antigens. Antigens are substances (usually proteins) on the surface of cells, viruses, fungi, or bacteria. Nonliving substances such as toxins, chemicals, drugs, and foreign particles (such as a splinter) can also be antigens. The immune system recognizes and destroys, or tries to destroy, substances that contain antigens.

Your body's cells have proteins that are antigens. These include a group of antigens called HLA antigens. Your immune system learns to see these antigens as normal and usually does not react against them.

INNATE IMMUNITY

Innate, or nonspecific, immunity is the defense system with which you were born. It protects you against all antigens. Innate immunity involves barriers that keep harmful materials from entering your body. These barriers form the first line of defense in the immune response. Examples of innate immunity include:

• Cough reflex
• Enzymes in tears and skin oils
• Mucus, which traps bacteria and small particles
• Skin
• Stomach acid

Innate immunity also comes in a protein chemical form, called innate humoral immunity. Examples include the body's complement system and substances called interferon and interleukin-1 (which causes fever).

If an antigen gets past these barriers, it is attacked and destroyed by other parts of the immune system.

ACQUIRED IMMUNITY

Acquired immunity is immunity that develops with exposure to various antigens. Your immune system builds a defense against that specific antigen.

PASSIVE IMMUNITY

Passive immunity is due to antibodies that are produced in a body other than your own. Infants have passive immunity because they are born with antibodies that are transferred through the placenta from their mother. These antibodies disappear between ages 6 and 12 months.

Passive immunization may also be due to injection of antiserum, which contains antibodies that are formed by another person or animal. It provides immediate protection against an antigen, but does not provide long-lasting protection. Immune serum globulin (given for hepatitis exposure) and tetanus antitoxin are examples of passive immunization.

BLOOD COMPONENTS

The immune system includes certain types of white blood cells. It also includes chemicals and proteins in the blood, such as antibodies, complement proteins, and interferon. Some of these directly attack foreign substances in the body, and others work together to help the immune system cells.

Lymphocytes are a type of white blood cell. There are B and T type lymphocytes.

• B lymphocytes become cells that produce antibodies. Antibodies attach to a specific antigen and make it easier for the immune cells to destroy the antigen.
• T lymphocytes attack antigens directly and help control the immune response. They also release chemicals, known as cytokines, which control the entire immune response.

As lymphocytes develop, they normally learn to tell the difference between your own body tissues and substances that are not normally found in your body. Once B cells and T cells are formed, a few of those cells will multiply and provide "memory" for your immune system. This allows your immune system to respond faster and more efficiently the next time you are exposed to the same antigen. In many cases, it will prevent you from getting sick. For example, a person who has had chickenpox or has been immunized against chickenpox is immune from getting chickenpox again.

INFLAMMATION

The inflammatory response (inflammation) occurs when tissues are injured by bacteria, trauma, toxins, heat, or any other cause. The damaged cells release chemicals including histamine, bradykinin, and prostaglandins. These chemicals cause blood vessels to leak fluid into the tissues, causing swelling. This helps isolate the foreign substance from further contact with body tissues.

The chemicals also attract white blood cells called phagocytes that "eat" germs and dead or damaged cells. This process is called phagocytosis. Phagocytes eventually die. Pus is formed from a collection of dead tissue, dead bacteria, and live and dead phagocytes.

IMMUNE SYSTEM DISORDERS AND ALLERGIES

Immune system disorders occur when the immune response is directed against body tissue, is excessive, or is lacking. Allergies involve an immune response to a substance that most people's bodies perceive as harmless.

IMMUNIZATION

Vaccination (immunization) is a way to trigger the immune response. Small doses of an antigen, such as dead or weakened live viruses, are given to activate immune system "memory" (activated B cells and sensitized T cells). Memory allows your body to react quickly and efficiently to future exposures.

COMPLICATIONS DUE TO AN ALTERED IMMUNE RESPONSE

An efficient immune response protects against many diseases and disorders. An inefficient immune response allows diseases to develop. Too much, too little, or the wrong immune response causes immune system disorders. An overactive immune response can lead to the development of autoimmune diseases, in which antibodies form against the body's own tissues.

Complications from altered immune responses include:

1. World Health Organization . The global burden of disease [database on the Internet]. 2013. [Cited 19 Aug 2013]. Available from URL: http://www.who.int/healthinfo/global_burden_disease/en/

2. Trunkey DD. Trauma. Accidental and intentional injuries account for more years of life lost in the U.S. than cancer and heart disease. Among the prescribed remedies are improved preventive efforts, speedier surgery and further research. Sci. Am. 1983; 249: 28–35. [PubMed] [Google Scholar]

3. Wafaisade A, Lefering R, Bouillon B et al Epidemiology and risk factors of sepsis after multiple trauma: an analysis of 29,829 patients from the Trauma Registry of the German Society for Trauma Surgery. Crit. Care Med. 2011; 39: 621–628. [PubMed] [Google Scholar]

4. Moore FA, Moore EE, Read RA. Postinjury multiple organ failure: role of extrathoracic injury and sepsis in adult respiratory distress syndrome. New Horiz. 1993; 1: 538–549. [PubMed] [Google Scholar]

5. Baue AE, Durham R, Faist E. Systemic inflammatory response syndrome (SIRS), multiple organ dysfunction syndrome (MODS), multiple organ failure (MOF): are we winning the battle? Shock 1998; 10: 79–89. [PubMed] [Google Scholar]

6. Baue AE. MOF, MODS, and SIRS: what is in a name or an acronym? Shock 2006; 26: 438–449. [PubMed] [Google Scholar]

7. Bone RC. Sir Isaac Newton, sepsis, SIRS, and CARS. Crit. Care Med. 1996; 24: 1125–1128. [PubMed] [Google Scholar]

8. Osuchowski MF, Welch K, Siddiqui J, Remick DG. Circulating cytokine/inhibitor profiles reshape the understanding of the SIRS/CARS continuum in sepsis and predict mortality. J. Immunol. 2006; 177: 1967–1974. [PubMed] [Google Scholar]

9. Matzinger P. The danger model: a renewed sense of self. Science 2002; 296: 301–305. [PubMed] [Google Scholar]

10. Harris HE, Raucci A. Alarmin(g) news about danger: workshop on innate danger signals and HMGB1. EMBO Rep. 2006; 7: 774–778. [PMC free article] [PubMed] [Google Scholar]

11. Oppenheim JJ, Yang D. Alarmins: chemotactic activators of immune responses. Curr. Opin. Immunol. 2005; 17: 359–365. [PubMed] [Google Scholar]

12. Manson J, Thiemermann C, Brohi K. Trauma alarmins as activators of damage‐induced inflammation. Br. J. Surg. 2012; 99(Suppl. 1): 12–20. [PubMed] [Google Scholar]

13. Matzinger P. An innate sense of danger. Ann. N. Y. Acad. Sci. 2002; 961: 341–342. [PubMed] [Google Scholar]

14. Ogura H, Tanaka H, Koh T et al Priming, second‐hit priming, and apoptosis in leukocytes from trauma patients. J. Trauma 1999; 46: 774–781, discussion 81–3. [PubMed] [Google Scholar]

15. Hoover L, Bochicchio GV, Napolitano LM et al Systemic inflammatory response syndrome and nosocomial infection in trauma. J. Trauma 2006; 61: 310–316, discussion 6–7. [PubMed] [Google Scholar]

16. Osuka A, Hanschen M, Stoecklein V, Lederer JA. A protective role for inflammasome activation following injury. Shock 2012; 37: 47–55. [PMC free article] [PubMed] [Google Scholar]

17. Mizushima Y, Ueno M, Idoguchi K, Ishikawa K, Matsuoka T. Fever in trauma patients: friend or foe? J. Trauma 2009; 67: 1062–1065. [PubMed] [Google Scholar]

18. Paterson HM, Murphy TJ, Purcell EJ et al Injury primes the innate immune system for enhanced Toll‐like receptor reactivity. J. Immunol. 2003; 171: 1473–1483. [PubMed] [Google Scholar]

19. Zang Y, Dolan SM, Ni Choileain N et al Burn injury initiates a shift in superantigen‐induced T cell responses and host survival. J. Immunol. 2004; 172: 4883–4892. [PubMed] [Google Scholar]

20. Maung AA, Fujimi S, MacConmara MP et al Injury enhances resistance to Escherichia coli infection by boosting innate immune system function. J. Immunol. 2008; 180: 2450–2458. [PubMed] [Google Scholar]

21. Southard R, Ghosh S, Hilliard J et al Pulmonary contusion is associated with toll‐like receptor 4 upregulation and decreased susceptibility to pseudomonas pneumonia in a mouse model. Shock 2012; 7: 629–633. [PMC free article] [PubMed] [Google Scholar]

22. Grossman JA, Adams JP, Kunec J. Prophylactic antibiotics in simple hand lacerations. JAMA 1981; 245: 1055–1056. [PubMed] [Google Scholar]

23. Fan J, Li Y, Levy RM et al Hemorrhagic shock induces NAD(P)H oxidase activation in neutrophils: role of HMGB1‐TLR4 signaling. J. Immunol. 2007; 178: 6573–6580. [PubMed] [Google Scholar]

24. Fan J, Kapus A, Li YH, Rizoli S, Marshall JC, Rotstein OD. Priming for enhanced alveolar fibrin deposition after hemorrhagic shock: role of tumor necrosis factor. Am. J. Respir. Cell Mol. Biol. 2000; 22: 412–421. [PubMed] [Google Scholar]

25. Bone RC. Immunologic dissonance: a continuing evolution in our understanding of the systemic inflammatory response syndrome (SIRS) and the multiple organ dysfunction syndrome (MODS). Ann. Intern. Med. 1996; 125: 680–687. [PubMed] [Google Scholar]

26. Sauaia A, Moore FA, Moore EE, Lezotte DC. Early risk factors for postinjury multiple organ failure. World J. Surg. 1996; 20: 392–400. [PubMed] [Google Scholar]

27. Ninnemann JL, Fisher JC, Frank HA. Prolonged survival of human skin allografts following thermal injury. Transplantation 1978; 25: 69–72. [PubMed] [Google Scholar]

28. Lederer JA, Rodrick ML, Mannick JA. The effects of injury on the adaptive immune response. Shock 1999; 11: 153–159. [PubMed] [Google Scholar]

29. Faist E, Schinkel C, Zimmer S. Update on the mechanisms of immune suppression of injury and immune modulation. World J. Surg. 1996; 20: 454–459. [PubMed] [Google Scholar]

30. De AK, Kodys KM, Pellegrini J et al Induction of global anergy rather than inhibitory Th2 lymphokines mediates posttrauma T cell immunodepression. Clin. Immunol. 2000; 96: 52–66. [PubMed] [Google Scholar]

31. Kelly JL, O'Suilleabhain CB, Soberg CC, Mannick JA, Lederer JA. Severe injury triggers antigen‐specific T‐helper cell dysfunction. Shock 1999; 12: 39–45. [PubMed] [Google Scholar]

32. Murphy T, Paterson H, Rogers S, Mannick JA, Lederer JA. Use of intracellular cytokine staining and bacterial superantigen to document suppression of the adaptive immune system in injured patients. Ann. Surg. 2003; 238: 401–410, discussion 10–1. [PMC free article] [PubMed] [Google Scholar]

33. O'Sullivan ST, Lederer JA, Horgan AF, Chin DH, Mannick JA, Rodrick ML. Major injury leads to predominance of the T helper‐2 lymphocyte phenotype and diminished interleukin‐12 production associated with decreased resistance to infection. Ann. Surg. 1995; 222: 482–490, discussion 90–2. [PMC free article] [PubMed] [Google Scholar]

34. Mack VE, McCarter MD, Naama HA, Calvano SE, Daly JM. Candida infection following severe trauma exacerbates Th2 cytokines and increases mortality. J. Surg. Res. 1997; 69: 399–407. [PubMed] [Google Scholar]

35. Guo Z, Kavanagh E, Zang Y et al Burn injury promotes antigen‐driven Th2‐type responses in vivo. J. Immunol. 2003; 171: 3983–3990. [PubMed] [Google Scholar]

36. Miyara M, Sakaguchi S. Natural regulatory T cells: mechanisms of suppression. Trends Mol. Med. 2007; 13: 108–116. [PubMed] [Google Scholar]

37. Sakaguchi S, Ono M, Setoguchi R et al Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self‐tolerance and autoimmune disease. Immunol. Rev. 2006; 212: 8–27. [PubMed] [Google Scholar]

38. Ni Choileain N, MacConmara M, Zang Y, Murphy TJ, Mannick JA, Lederer JA. Enhanced regulatory T cell activity is an element of the host response to injury. J. Immunol. 2006; 176: 225–236. [PubMed] [Google Scholar]

39. MacConmara MP, Tajima G, O'Leary F et al Regulatory T cells suppress antigen‐driven CD4 T cell reactivity following injury. J. Leukoc. Biol. 2011; 89: 137–147. [PMC free article] [PubMed] [Google Scholar]

40. Hanschen M, Tajima G, O'Leary F, Ikeda K, Lederer JA. Injury induces early activation of T‐cell receptor signaling pathways in CD4+ regulatory T cells. Shock 2011; 35: 252–257. [PMC free article] [PubMed] [Google Scholar]

41. Caretto D, Katzman SD, Villarino AV, Gallo E, Abbas AK. Cutting edge: the Th1 response inhibits the generation of peripheral regulatory T cells. J. Immunol. 2010; 184: 30–34. [PMC free article] [PubMed] [Google Scholar]

42. Frame JD, Eve MD, Hackett ME et al The toxic shock syndrome in burned children. Burns Incl. Therm. Inj. 1985; 11: 234–241. [PubMed] [Google Scholar]

43. McAllister RM, Mercer NS, Morgan BD, Sanders R. Early diagnosis of staphylococcal toxaemia in burned children. Burns 1993; 19: 22–25. [PubMed] [Google Scholar]

44. Maung AA, Fujimi S, Miller ML, MacConmara MP, Mannick JA, Lederer JA. Enhanced TLR4 reactivity following injury is mediated by increased p38 activation. J. Leukoc. Biol. 2005; 78: 565–573. [PubMed] [Google Scholar]

45. MacConmara MP, Maung AA, Fujimi S et al Increased CD4+ CD25+ T regulatory cell activity in trauma patients depresses protective Th1 immunity. Ann. Surg. 2006; 244: 514–523. [PMC free article] [PubMed] [Google Scholar]

46. Monneret G, Debard AL, Venet F et al Marked elevation of human circulating CD4+CD25+ regulatory T cells in sepsis‐induced immunoparalysis. Crit. Care Med. 2003; 31: 2068–2071. [PubMed] [Google Scholar]

Page 2

Immune system activation pathway following injury. The inflammasome is a large multiprotein complex that plays a key role in innate immunity by participating in the production of pro‐inflammatory cytokines such as interleukin (IL)‐1β and IL‐18. They are both produced as inactive precursors, pro‐IL‐1β and pro‐IL‐18, and share a common maturation mechanism that requires activated caspase‐1. The inflammasomes sense damage‐associated molecular patterns including pathogen‐associated molecular patterns (PAMPs) and the host‐derived signals known as alarmins. Cell death induced by inflammasome activation is known as pyroptosis. Alarmins also stimulate Toll‐like receptors (TLRs), which produce IL‐6 and tumor necrosis factor (TNF)‐α in response to injury. NF‐κB, nuclear factor‐κB.

Click on the image to see a larger version.